News
The European Commission is looking for success stories and inspirational examples of supervision practice across the Marie Sklodowska-Curie Actions (MSCA) community, to prepare an evidence-based guidance document that will support the existing MSCA guidelines on supervision.
The European Commission has published a survey to gather the examples and stories on the following key themes addressed in the guidelines:
The survey is targeted to researchers and research support personnel who have been involved in MSCA projects. This includes doctoral and postdoctoral fellows, academic and non-academic supervisors, mentors, coaches, administrative and technical staff.
The deadline to share the experience or best practice example is 2 September 2024.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
ESA Space Solutions has opened a call for proposals on space-enabled solutions for resilient electricity grids, in collaboration with ENTSO-E. The call supports proof-of-concept studies and pilot projects that address challenges in grid resilience and operational continuity.
Read moreThe Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.
Read moreThe European Commission and ESA have launched a new website for the Earth System Science Initiative (ESSI). The site brings together collaborative research on climate change, biodiversity loss, ocean health and other environmental challenges. It presents participating projects, scientific alliances and emerging results from EU- and ESA-supported research.
Read moreThe launch of the 2027 calls for proposals under the Defence-related Research Action (DEFRA) programme has been postponed until Spring 2027. As a result, the information days initially scheduled for 23 and 24 November 2026 will also be postponed. A revised timeline will be communicated as soon as it becomes available.
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
